NAGE Q1 2019 Earnings — Niagen Bioscience Inc Revenue & Financial Results | Market Cap Arena

NAGENiagen Bioscience Inc

$393M

Q1 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$10M+53.0% YoY

Gross Profit

$5M52.8% margin

Operating Income

-$8M-83.3% margin

Net Income

-$8M-83.0% margin

EPS (Diluted)

$-0.15

QoQ Revenue Growth

+10.8%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$3M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$42M

Total Liabilities

$21M

Stockholders' Equity

$21M

Cash & Equivalents

$19M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$10M	$7M	+53.0%
Gross Profit	$5M	$3M	+69.0%
Operating Income	-$8M	-$8M	+0.3%
Net Income	-$8M	-$8M	+1.3%